TG Therapeutics, Inc. (TGTX): Shares Outstanding
155.31M
As of 2025-12-31
153.08M
As of 2026-06-30
+2.0%
3-year compound annual growth
+2.0%
5-year compound annual growth
+11.1%
10-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 155.31M | -0.3% | 2026-02-27, Balance as of period end |
| 2024-12-31 | 155.84M | +2.9% | 2026-02-27, Balance as of period end |
| 2023-12-31 | 151.42M | +3.4% | 2025-03-03, Balance as of period end |
| 2022-12-31 | 146.39M | +2.2% | 2024-02-29, Balance as of period end |
| 2021-12-31 | 143.25M | +1.9% | 2023-03-01, Balance as of period end |
| 2020-12-31 | 140.58M | +28.5% | 2022-03-01, Balance as of period end |
| 2019-12-31 | 109.38M | +30.4% | 2021-03-01, Balance as of period end |
| 2018-12-31 | 83.87M | +14.7% | 2020-03-02, Balance as of period end |
| 2017-12-31 | 73.14M | +28.8% | 2019-03-01, Balance as of period end |
| 2016-12-31 | 56.78M | +5.0% | 2018-03-15, Balance as of period end |
| 2015-12-31 | 54.05M | +20.3% | 2017-03-16, Balance as of period end |
| 2014-12-31 | 44.93M | +31.0% | 2016-03-15, Balance as of period end |
| 2013-12-31 | 34.29M | +32.9% | 2015-03-16, Balance as of period end |
| 2012-12-31 | 25.81M | n/c | 2014-03-07, Balance as of period end |
| 2011-12-31 | 5.06M | n/a | 2013-03-21, Balance as of period end |